High-dose vitamin D supplementation reduces disease activity in clinically isolated syndrome typical of MS, results of a ...

Scientists have long suspected that gut bacteria may influence a person’s risk of developing multiple sclerosis. But studies ...

A SPECIFIC microbial ratio in the gut microbiome, characterised by a lower Bifidobacterium to Akkermansia ratio, has been ...

Certain immune cells in MS show abnormalities in activity and signs of reactions against the Epstein-Barr virus, a study says ...

Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, ...

New research highlights a critical link between antibodies produced against Epstein-Barr virus (EBV) and the development of ...

Neurons collected from brain lesions in MS patients were found to accumulate new genetic mutations faster than healthy nerve ...

In this interview, Dr Tiffany Braley discusses the results of her latest study and best practices for personalized patient ...

Scientists from Sweden’s Karolinska Institutet have uncovered new clues about how the Epstein-Barr virus (EBV) might ...

Scientists have long suspected that gut bacteria may influence a person’s risk of developing multiple sclerosis. But studies so far have had inconsistent findings. To address these ...

France: A recent randomized clinical trial, the D-Lay MS study, has demonstrated that high-dose vitamin D supplementation may ...

Multiple sclerosis is a disease that results when the immune system mistakenly attacks the brain and spinal cord. It ...